SUBSTITUTED 3,7-DIAZABICYCLO[3,3,1]NONANES, FOCUSED LIBRARY AND COMBINATORY LIBRARY

FIELD: organic chemistry, medicine, pharmacology. SUBSTANCE: invention relates to new enantiomeric, diastereomeric or stereoisomeric 3,7- diazabicyclo[3.3.1]nonanes of the general formula (1) as bases or salts of pharmacologically acceptable acids that showed in testing high activity with respect to...

Full description

Saved in:
Bibliographic Details
Main Authors VVEDENSKIJ V.JU, KHVAT ALEKSANDR VIKTOROVICH, TKACHENKO S.E, SANDULENKO JU.B, IVASHCHENKO A.V, OKUN' IL'JA MATUSOVICH
Format Patent
LanguageEnglish
Russian
Published 20.05.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:FIELD: organic chemistry, medicine, pharmacology. SUBSTANCE: invention relates to new enantiomeric, diastereomeric or stereoisomeric 3,7- diazabicyclo[3.3.1]nonanes of the general formula (1) as bases or salts of pharmacologically acceptable acids that showed in testing high activity with respect to nicotine receptors. Invention relates also to the focused and combinatory libraries of these compounds. In compounds of the formula (1) R1 represents ; each among R2, R3, R5, R6 represents independently hydrogen atom, inert substituent, NH-protective substituent, electrophilic substituent, nucleophilic substituent; R2 and R3 represent in common: -C(O)-, -C(S)-, -C(O)- C(O)-, -CHR8-, -(CH2)k-CR7R8, S(O)n, n = 1, 2; k = 1-3; R1 and R3 or R1 and R2 represent in common group C=O; R4 represents halogen atom, sulfonyloxy-group (for example, tosyl group) or acyloxy-group (for example, acetate); NR5R6 represent in common azaheterocyclyl or substituted azaheterocyclyl; R7 and R8 each represents independently: hydrogen atom, inert substituent. EFFECT: valuable medicinal and pharmacological properties of compounds. 35 cl, 1 tbl, 15 ex
Bibliography:Application Number: RU20030114720